Ashland Under Investigation Amid Stock Plunge
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 19 2026
0mins
Source: Globenewswire
- Securities Fraud Investigation: Pomerantz LLP is investigating whether Ashland Inc. has engaged in securities fraud or other unlawful business practices, which could undermine investor confidence and lead to further stock declines.
- Underperformance Report: In its Q2 2026 results, Ashland reported revenue and non-GAAP earnings per share that fell short of consensus estimates, with CEO Guillermo Novo citing operational challenges at the Hopewell manufacturing facility as a significant factor impacting overall performance.
- Revised Full-Year Guidance: The company updated its full-year sales and EBITDA guidance to reflect productivity challenges associated with the ramp-up at Hopewell, as well as softer energy-related demand due to the Middle East conflict, which may adversely affect future performance.
- Stock Price Plunge: Following the disappointing earnings announcement, Ashland's stock price fell by $7.85, or 13.77%, closing at $49.15 per share on April 29, 2026, indicating market concerns regarding the company's outlook.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ASH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ASH
Wall Street analysts forecast ASH stock price to rise
9 Analyst Rating
6 Buy
3 Hold
0 Sell
Moderate Buy
Current: 64.870
Low
53.00
Averages
66.67
High
73.00
Current: 64.870
Low
53.00
Averages
66.67
High
73.00
About ASH
Ashland Inc. is a global additives and specialty ingredients company. The Company serves customers in a range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceuticals. The Company's segments include Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment consists of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films and fine chemicals. The Personal Care segment includes functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The Specialty Additives segment consists of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. The Intermediates segment consists of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Activist Investor Stake: Activist investor Ancora Alternatives began building its position in Ashland (ASH) in April, leading to a 6.3% rise in share price, reflecting market confidence in the company's future prospects.
- Potential Sale Value: Ancora believes Ashland could be sold for at least $76 per share, representing a 31% increase from current levels, indicating the market's recognition of its intrinsic value and potential appeal to strategic investors.
- Proxy Fight Preparedness: Ancora is ready to initiate a proxy fight if Ashland does not make tangible progress toward a deal by the September director nomination window, highlighting its strong focus on corporate governance.
- Financial Outlook: Ashland projects fiscal 2026 sales between $1.835 billion and $1.87 billion, with adjusted EBITDA of $385 million to $400 million, despite facing $10 million to $12 million in savings cuts due to delays in the Hopewell project.
See More
- Stock Performance: Ashland Inc shares traded at $64.90, surpassing the 12-month analyst target price of $64.33, indicating increased market confidence in the company.
- Analyst Reactions: When a stock hits an analyst's target, they may downgrade or raise their price target, reflecting differing views on fundamental business developments, which could influence investor decisions.
- Target Price Distribution: Among the 12 analysts covered by Zacks, target prices range from $50.00 to $75.00, with a standard deviation of $6.678, highlighting varying expectations for Ashland Inc's future performance.
- Investor Signal: With the stock price exceeding the average target, investors are prompted to reassess the company, considering whether the current valuation is justified or if it’s time to take profits to mitigate risk.
See More
- Board Commitment: Ashland's Board of Directors and management are dedicated to creating sustainable value for all shareholders, emphasizing respect for diverse perspectives and welcoming constructive feedback, indicating the company's commitment to shareholder communication.
- Ongoing Dialogue Plan: Although Ancora did not engage with Ashland prior to its presentation, Ashland intends to engage with them consistently to strengthen ongoing dialogue with investors, demonstrating the company's focus on shareholder relations.
- Focus on Growth Strategy: Ashland is concentrating on globalization, innovation, and investment while improving operational performance and cash generation, with expectations that these priorities will drive the company’s transformation into sustained financial and operational performance.
- Strategic Evaluation Mechanism: The Board regularly evaluates the company's strategy and value creation opportunities, including reviews of the operating plan, portfolio priorities, and capital policy, ensuring decisions align with the best interests of the company and all shareholders.
See More
- Increased Shareholder Pressure: Activist investor Ancora Alternatives has built a significant stake in Ashland Inc (ASH.N) and argues that a sale could boost the share price by at least 30%, demonstrating strong confidence in the company's future value.
- Background of Stock Decline: Since hitting a high in December 2022, Ashland's stock price has tumbled roughly 50%, now trading near $57.50, reflecting investor punishment for disappointing performance, with a market value of only $2.7 billion.
- Acquisition Potential Analysis: Ancora forecasts that a sale could push the stock price to at least $76, marking a 31% increase, indicating that the company's intrinsic value remains underappreciated amid current trading discounts and growth challenges.
- Possibility of Management Changes: Ancora is prepared to launch a proxy fight during the upcoming shareholder nomination window if constructive dialogue with management does not yield a resolution, aiming to add fresh leadership to the board to ensure proper fiduciary oversight.
See More
- Investigation Launched: Pomerantz LLP is investigating claims on behalf of Ashland Inc. investors, focusing on whether the company and its executives engaged in securities fraud or other unlawful business practices, which could further impact the company's reputation and stock price.
- Disappointing Performance: In Q2 2026, Ashland reported revenue and non-GAAP earnings per share that fell short of consensus estimates, with CEO Guillermo Novo indicating that operational challenges significantly impacted overall results, highlighting issues in production efficiency.
- Outlook Adjustment: The company updated its full-year sales and EBITDA guidance to reflect productivity challenges associated with the ramp-up at the Hopewell manufacturing facility and softer energy-related demand due to the Middle East conflict, which may further affect future financial performance.
- Stock Price Reaction: Following the disappointing earnings announcement, Ashland's stock price fell by $7.85, or 13.77%, closing at $49.15 per share on April 29, 2026, indicating market concerns regarding the company's outlook.
See More
- Securities Fraud Investigation: Pomerantz LLP is investigating whether Ashland Inc. has engaged in securities fraud or other unlawful business practices, which could undermine investor confidence and lead to further stock declines.
- Underperformance Report: In its Q2 2026 results, Ashland reported revenue and non-GAAP earnings per share that fell short of consensus estimates, with CEO Guillermo Novo citing operational challenges at the Hopewell manufacturing facility as a significant factor impacting overall performance.
- Revised Full-Year Guidance: The company updated its full-year sales and EBITDA guidance to reflect productivity challenges associated with the ramp-up at Hopewell, as well as softer energy-related demand due to the Middle East conflict, which may adversely affect future performance.
- Stock Price Plunge: Following the disappointing earnings announcement, Ashland's stock price fell by $7.85, or 13.77%, closing at $49.15 per share on April 29, 2026, indicating market concerns regarding the company's outlook.
See More







